ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 160,16
0,43%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Mast Therapeutics, Inc. (ANX)

  7. Mast Therapeutics, Inc. (ANX) Actualités

ANX

Adventrx (ANX)

Mast Therapeutics, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:ANX
DateHeureSourceTitreSymboleSociété
27/04/201509h21Analyst Ratings NetworkRoth Capital Initiates Coverage on Mast Therapeutics (ANX)AMEX:ANXMast Therapeutics, Inc.
16/06/201414h00PR Newswire (US)Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC TrialAMEX:ANXMast Therapeutics, Inc.
14/04/201414h00PR Newswire (US)Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell DiseaseAMEX:ANXMast Therapeutics, Inc.
10/02/201414h00PR Newswire (US)Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.AMEX:ANXMast Therapeutics, Inc.
03/09/201314h00PR Newswire (US)Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10AMEX:ANXMast Therapeutics, Inc.
11/03/201313h00PR Newswire (US)ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"AMEX:ANXMast Therapeutics, Inc.
01/03/201322h11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
28/02/201323h15PR Newswire (US)ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"AMEX:ANXMast Therapeutics, Inc.
28/02/201322h01PR Newswire (US)Adventrx To Develop ANX-188 For Complications Of Arterial DiseaseAMEX:ANXMast Therapeutics, Inc.
26/02/201314h00PR Newswire (US)ADVENTRX Reviews Data Supporting Development Of ANX-188 In New IndicationsAMEX:ANXMast Therapeutics, Inc.
25/02/201314h00PR Newswire (US)ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4AMEX:ANXMast Therapeutics, Inc.
11/02/201314h00PR Newswire (US)ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
05/02/201314h00PR Newswire (US)ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12AMEX:ANXMast Therapeutics, Inc.
30/01/201313h00PR Newswire (US)ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
19/01/201300h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
10/01/201315h55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ANXMast Therapeutics, Inc.
10/01/201315h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:ANXMast Therapeutics, Inc.
04/01/201314h00PR Newswire (US)ADVENTRX Announces Appointment of Chief Financial OfficerAMEX:ANXMast Therapeutics, Inc.
03/01/201322h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201312h07Edgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
02/01/201314h00PR Newswire (US)ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8AMEX:ANXMast Therapeutics, Inc.
19/12/201222h19Edgar (US Regulatory)Other Filing (40-app/a)AMEX:ANXMast Therapeutics, Inc.
19/12/201214h00PR Newswire (US)ADVENTRX To Initiate Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
03/12/201214h30PR Newswire (US)ADVENTRX Announces Launch Of New Corporate WebsiteAMEX:ANXMast Therapeutics, Inc.
05/11/201223h03Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANXMast Therapeutics, Inc.
05/11/201214h00PR Newswire (US)ADVENTRX Reports Third Quarter 2012 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
25/10/201222h05PR Newswire (US)ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
23/10/201214h30PR Newswire (US)ADVENTRX Announces Conference Call To Review Protocol For Phase 3 Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
02/10/201214h00PR Newswire (US)ADVENTRX Engages Theradex Systems, Inc. to Manage Phase 3 Clinical Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
07/09/201218h58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ANXMast Therapeutics, Inc.
 Showing the most relevant articles for your search:AMEX:ANX

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
ORA
Orange
EU
DG
Vinci
EU
SGO
Cie de SaintGobain
NYSE
NKE
Nike
EU
VIV
Vivendi
EU
PX1
CAC 40
EU
GLE
Societe Generale
EU
AI
Air Liquide
EU
HO
Thales
NYSE
KO
Coca Cola
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés